{
  "image_filename": "figure_p1_det_0_005.png",
  "image_path": "Treanor_et_al.__2011_/extracted/figures/figure_p1_det_0_005.png",
  "image_type": "Figure",
  "page_number": 1,
  "block_id": "det_0_005",
  "claim_id": "claim_003",
  "claim": "Recombinant technology leads to a broader immune response that may provide cross-protection, even in a mismatch season.",
  "supports_claim": false,
  "explanation": "Partial capture of page 1 header from the journal Vaccine (Elsevier) showing the journal name, homepage URL, and the beginning of the article title regarding the efficacy of a trivalent recombinant hemagglutinin protein vaccine. does not support the claim Note: Only the header and partial title are visible; no data or figure content is shown to assess immune response breadth or cross-protection.",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "Partial capture of page 1 header from the journal Vaccine (Elsevier) showing the journal name, homepage URL, and the beginning of the article title regarding the efficacy of a trivalent recombinant hemagglutinin protein vaccine.",
    "evidence_found": null,
    "reasoning": "does not support the claim",
    "confidence_notes": "Only the header and partial title are visible; no data or figure content is shown to assess immune response breadth or cross-protection."
  }
}